Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
BC Platforms Expands Data Partner Network with Major Brazilian Cardiovascular Health Institution
BC Platforms (BCP), a global leader in healthcare data management and analytics, today announces the […]
Notable launches Patient AI, the world's first use of large language models and GPT to bring personalization at scale to healthcare
Notable, the leading intelligent automation company for healthcare, launched Patient AI, the world’s first use […]
Canaan Closes $850 Million to Continue 35-Year History of Building and Supporting Transformational Technology and Healthcare Companies
Canaan today announced $850 million in new capital to continue the firm’s 35-year history of […]
MOLLI Surgical Launches Breakthrough Products to Simplify Breast Cancer Surgery and Deliver a Better Patient Experience
MOLLI Surgical, the company that is pushing the boundaries of precision surgery for breast cancer, […]
Fujitsu launches Cloud-based Platform for Healthcare in Japan
Fujitsu today announced the launch of a new cloud-based platform that allows users to securely […]
Hikma Expands Impact in Canada with Launches of New Sterile Injectable Medicines
Hikma Pharmaceuticals, the multinational pharmaceutical company, announces the launch of four new sterile injectable medicines […]
Roche Expands Collaboration with Janssen to Advance Personalised Healthcare Through Companion Diagnostics
Roche today announced that it has expanded its collaboration with Janssen Biotech Inc. (Janssen) to […]
Spectrum Science Receives Strategic Investment from Knox Lane to Fuel Continued Growth
Spectrum Science, an independent, integrated marketing, communications and media firm focused on the pharmaceutical, biotech […]
Mihir Patel Joins Cambia Health Solutions as Chief Pharmacy Officer
Cambia Health Solutions has named Mihir Patel, Pharm.D., RPh, as its Chief Pharmacy Officer. In this […]
Novalis Biotech Invests in Ultra Sensitive Genomics Technology by Rarity Bioscience
Rarity Bioscience announces a new strategic investment from Belgium-based Novalis Biotech. The investment is facilitated […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more